Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AFTER-CV: Cardioversion Methods and Stroke Risk in Atrial Fibrillation
NCT01924065Phase 3Completed
- Sponsor
- Suleyman Demirel University
- Start
- Aug 2013
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of warfarin, dabigatran etexilate oral solution, rivaroxaban, apixaban, edoxaban in Atrial fibrillation (AFib), sponsored by Suleyman Demirel University. Started Aug 2013; status: completed.
02
Drugs
warfarindabigatran etexilate oral solutionrivaroxabanapixabanedoxaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT01924065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01924065.